Ozempic use spreads in sororities as college women reportedly chase thinness
NEWYou can now listen to Fox News articles! As GLP-1 medications continue to surge in popularity for weight…
Possibly problematic drug combos commonly prescribed to older adults
Share on PinterestA new study identifies 24 common, and potentially inappropriate, prescribing cascades that may result in medication-related…
Hundreds of lawsuits filed against some GLP-1 Makers over vision loss
Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
New lawsuits claim GLP-1 drugs led to vision loss – abcnews.com
New lawsuits claim GLP-1 drugs led to vision loss abcnews.comPatients Sue GLP-1 Drugmakers Over Risk of Sudden Vision Loss wsj.comAre…
Andrographis dropped from listed medicines framework
ajp.com.au This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional…
Medicare Part D Plans Paid $562 Million for Generic Voltaren. A Doctor’s Prescription Still Doesn’t Make an OTC Drug Part D-Eligible
A doctor’s prescription cleared millions of pharmacy claims through Medicare Part D for a drug the program was…
What is ibogaine, and what does it treat?
Ibogaine, a psychoactive compound made from the roots of an African shrub, has been gaining popularity as a…
Illinois Gov. JB Pritzker says he has lost 80 pounds on ‘life-changing’ GLP-1 medication
Illinois Gov. JB Pritkzer says he has lost 80 pounds while using a “life-changing” GLP-1 medication since he…
Stopping Ozempic may raise heart attack and stroke risk
GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have surged in popularity for…
Stopping Ozempic may raise heart attack and stroke risk
GLP-1 drugs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have surged in popularity for…
The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?
Morgan Stanley has cut Novo Nordisk A/S (NYSE:NVO) to Underweight on September 11, 2026. Semaglutide, the underlying molecule…
Karnataka cancels 16 licences, suspends 8 over spurious drugs: Full list
The Karnataka Food Safety and Drugs Administration (FSDA) has cancelled the licences of 16 pharmaceutical retailers and wholesalers,…